Tratamiento con interferón alfa-2B recombinante en el carcinoma basocelular
Coperchini F, Pignatti P, Sideri R, Groppelli G, Leporati P, et al. Interferon-gamma and tumor necrosis factor-alpha sustain secretion of specific cxc chemokines in human thyrocytes: A first step toward a differentiation between autoimmune and tumor-related inflammation? J Clin Endocrinol Metab. 2013 Ene;98(1):308-13.
Navarro Mestre M. Estudio de dosis óptima del heberpag perilesional en el carcinoma basocelular de piel [Tesis]. Ciudad de la Habana: Universidad Médica; 2009.
Rueda X, Acosta A, Aristizaral L, Fierro E. Guías de práctica clínica para el tratamiento del carcinoma basocelular. Rev Asoc Colom 2008; 16:(2):22-27.
Mackiewicz-Wysocka M, Bowszyc-Dmochowska M, Strzelecka-Weklar D, Danczak-Pazdrowska A, Adamski Z. Basal cell carcinoma – diagnosis. Contemp Oncol (Pozn). [Review]. 2013;17(4):337-42.
Lazareth V. Management of non-melanoma skin cancer. Semin Oncol Nurs. 2013 Ago;29(3):182-94.
Norval M, Kellett P, Wright CY. The incidence and body site of skin cancers in the population groups of south africa. Photodermatol Photoimmunol Photomed. 2014 Ene 14.
Cohen PR. Basal cell carcinoma of the axilla: Review of the world literature. Am J Clin Dermatol. 2014 Feb 25.
Kirkham N. Tumors and Cysts of the epidermis. Elder DE, Elenitsas R, Johnson B, Jaworsky C. En: Lever´s histopathlogy of the skin. 9th ed. Philadelphia: Lippincott Wilkins; 2006.p.617-654.
Chinem VP, Miot HA. Epidemiologia do carcinoma basocelular. An Bras Dermatol. 2011;86:292-305.
Barón Estrada óI, álvarez Sierra J, Montealegre Gómez G. Análisis retrospectivo del carcinoma cutáneo tipo basocelular y escamocelular en bogotá-colombia: Epidemiología, prevención y tratamiento. Revista Facultad de Medicina de la Universidad Nacional de Colombia. 2009;57:40-8.
Carneiro RC, Macedo EMSd, Lima PPd, Matayoshi S. Terapia fotodinâmica em carcinoma basocelular periocular: Relato de caso. Revista Brasileira de Oftalmologia. 2012;71:394-6.
Mantese SAO, Berbert ALCV, Gomides MDA, Rocha A. Carcinoma basocelular – análise de 300 casos observados em uberlândia – mg. An Bras Dermatol. 2006;81:136-42.
Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (sins): A multicentre, non-inferiority, randomised controlled trial. Lancet Oncol. 2014 Ene;15(1):96-105.
Yan J, Liu L, Qian J. Reconstruction of upper eyelid and medial canthus following basal cell carcinoma resection: A successful one-stage repair with three local flaps. Int J Dermatol. [Case Reports]. 2013 May;52(5):611-3.
Shimizu I, Cohen PR, Macfarlane DF. Surgical treatment of basal cell carcinoma of the nail unit. Int J Dermatol. 2013 Ago;52(8):996-8.
Kiuru M, McDermott G, Coit DC, Berger MF, Busam KJ. Basal cell carcinosarcoma with ptch1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis. Am J Surg Pathol. [Case Reports]. 2014 Ene;38(1):138-42.
Zhang LY, Gao LX, Liu G, Yang GZ, Cheng J, Ding HY. Iinvasive lobular carcinoma of basal-like subtype of breast: A clinicopathologic analysis. Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):599-603.
Sharma S, Agrawal U, Gupta P, Bhatnagar A, Jairajpuri Z. Malignant melanoma and basal cell carcinoma of the face: A rare coexistence. Ann Saudi Med. [Case Reports]. 2013 May-Jun;33(3):304-6.
Latest mohs skin cancer surgery guidelines. Zeroing in on who might be eligible for this first-line treatment. Harv Health Lett. 2013 Feb;38(4):6.
Chiriac A, Mihaila D, Foia L, Solovan C. Basal cell carcinomas in elderly patients treated by cryotherapy. Clin Interv Aging. [Case Reports]. 2013;8:341-4.
Arepalli S, Kaliki S, Shields CL, Emrich J, Komarnicky L, Shields JA. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: An analysis of 15 eyes. JAMA Ophthalmol. 2014 Feb 20.
Jalian HR, Avram MM, Stankiewicz KJ, Shofner JD, Tannous Z. Combined 585 nm pulsed-dye and 1,064 nm nd:Yag lasers for the treatment of basal cell carcinoma. Lasers Surg Med. 2014 Ene;46(1):1-7.
Sahai P, Singh K, Sharma S, Kashyap S, Mohanti BK. Basal cell carcinoma in a child with xeroderma pigmentosum: Clinical response with electron beam radiation therapy. Indian J Dermatol Venereol Leprol. 2013 Jul-Ago;79(4):533-5.
Diaz Plasencia J, Tantalean – Ramella E, Garcia Peralta C. Cáncer de piel no melanoma: Aspectos clínicos – patológicos. Revista Medica Herediana. 1995;6:83-92.
Amini S, Viera MH, Valins W, Berman B. Nonsurgical innovations in the treatment of nonmelanoma skin cancer. J Clin Aesthet Dermatol. 2010 Jun;3(6):20-34.
Goldenberg G, Hamid O. Nonsurgical treatment options for basal cell carcinoma – focus on advanced disease. J Drugs Dermatol. [Research Support, Non-U.S. Gov’t]. 2013 Dic;12(12):1369-78.
Janier M. [what’s new in clinical dermatology?]. Ann Dermatol Venereol. 2013 Nov;140 Suppl 3:S237-53.
Basset-Seguin N. What’s new in dermato-oncology? Ann Dermatol Venereol. 2011 Dic;138 Suppl 4:S253-62.
Skelton LA. The effective treatment of basal cell carcinoma. Br J Nurs. 2009 Mar 26-Abr 8;18(6):346, 8-50.
Dummer R. Treating basal-cell carcinoma in a real life setting. Lancet Oncol. [Comentario]. 2013 Jun;14(7):572-3.
Botto N, Rogers G. Nontraditional management of basal cell carcinoma. J Drugs Dermatol. [Review]. 2013 May;12(5):525-32.
Sun X, Jiang R, Przepiorski A, Reddy S, Palmano KP, Krissansen GW. «Iron-saturated» bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice. BMC Cancer. [Research Support, Non-U.S. Gov’t]. 2012;12:591.
Petrunin DD, Okovityi SV, Kostalevskaia AV, Suchkov SV. [aproaches to immunotherapy in different immunophenotypes of cutaneous basal cell carcinoma]. Vopr Onkol. 2012;58(3):406-12, 15.
Good LM, Miller MD, High WA. Intralesional agents in the management of cutaneous malignancy: A review. J Am Acad Dermatol. [Review]. 2011 Feb;64(2):413-22.
Chu CY, Cha ST, Lin WC, Lu PH, Tan CT, Chang CC, et al. Stromal cell-derived factor-1alpha (sdf-1alpha/cxcl12)-enhanced angiogenesis of human basal cell carcinoma cells involves erk1/2-nf-kappab/interleukin-6 pathway. Carcinogenesis. [Research Support, Non-U.S. Gov’t]. 2009 Feb;30(2):205-13.
Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R, et al. New response evaluation